Herrera R E, Sah V P, Williams B O, Mäkelä T P, Weinberg R A, Jacks T
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
Mol Cell Biol. 1996 May;16(5):2402-7. doi: 10.1128/MCB.16.5.2402.
Fibroblasts prepared from retinoblastoma (Rb) gene-negative mouse embryos exhibit a shorter G1 phase of the growth cycle and smaller size than wild-type cells. In addition, the mutant cells are no longer inhibited by low levels of cycloheximide at any point in G1 but do remain sensitive to serum withdrawal until late in G1. Certain cell cycle-regulated genes showed no temporal or quantitative differences in expression. In contrast, cyclin E expression in Rb-deficient cells is deregulated in two ways. Cyclin E mRNA is generally derepressed in mutant cells and reaches peak levels about 6 h earlier in G1 than in wild-type cells. Moreover, cyclin E protein levels are higher in the Rb-/- cells than would be predicted from the levels of its mRNA. Thus, the selective growth advantage conferred by Rb gene deletion during tumorigenesis may be explained in part by changes in the regulation of cyclin E. In addition, the mechanisms defining the restriction point of late G1 may consist of at least two molecular events, one cycloheximide sensitive and pRb dependent and the other serum sensitive and pRb independent.
从视网膜母细胞瘤(Rb)基因阴性小鼠胚胎制备的成纤维细胞,与野生型细胞相比,生长周期的G1期更短,细胞体积更小。此外,突变细胞在G1期的任何时间点都不再受低水平放线菌酮的抑制,但对血清撤除仍保持敏感,直至G1期末期。某些细胞周期调控基因在表达上没有时间或数量上的差异。相反,Rb缺陷细胞中的细胞周期蛋白E表达以两种方式失调。细胞周期蛋白E mRNA在突变细胞中通常去抑制,并且在G1期比野生型细胞早约6小时达到峰值水平。此外,Rb-/-细胞中的细胞周期蛋白E蛋白水平高于根据其mRNA水平预测的水平。因此,Rb基因缺失在肿瘤发生过程中赋予的选择性生长优势,可能部分归因于细胞周期蛋白E调控的变化。此外,定义G1期末期限制点的机制可能至少由两个分子事件组成,一个对放线菌酮敏感且依赖pRb,另一个对血清敏感且不依赖pRb。